ASPERGILLUS SP - ANVISA Registration 81816720042

Access comprehensive regulatory information for ASPERGILLUS SP in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81816720042 and manufactured by VIRCELL S.L.. The registration is held by ALIFAX BRASIL COMER., EXP., IMP., DIST. DE EQUIPAMENTOS E REAGENTES PARA DIAGNOSTICO IN VITRO LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including GENOBIO PHARMACEUTICAL CO., LTD, INSTITUT VIRION\SERION GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
81816720042
Registration Details
ANVISA Registration Number: 81816720042
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

ASPERGILLUS GALACTOMANNAN AG VIRCLIA® MONOTEST
Risk Class II

Registration Details

81816720042

25351457141202346

31167508000102

Company Information

Dates and Status

Aug 14, 2023

VIGENTE

09/18/2025 19:00:01